Intraocular Pharmacokinetics of Erythropoietin After Single Intravitreal Injection in Human
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01131533|
Recruitment Status : Unknown
Verified September 2010 by Hallym University Medical Center.
Recruitment status was: Recruiting
First Posted : May 27, 2010
Last Update Posted : September 15, 2010
|Condition or disease||Intervention/treatment||Phase|
|Pharmacokinetics Erythropoietin||Procedure: Vitrectomy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||5 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Intraocular Pharmacokinetics of Erythropoietin After Single Intravitreal Injection in Human|
|Study Start Date :||January 2009|
|Actual Primary Completion Date :||July 2010|
|Estimated Study Completion Date :||December 2011|
patients with chronic macular edema associated with diabetic retinopathy
vitrectomy following intravitreal erythropoietin
- Concentration of erythropoietin in aqueous humor [ Time Frame: a few seconds ]erythropoietin injections had been performed in our department following standard procedures. In selected cases,vitrectomy was performed one to two days after erythropoietin injection to treat diabetic macular edema.During surgery, aqueous humor samples were obtained via a corneal paracentesis anterior to the limbus at the beginning of the procedure.
- Concentration of erythropoietin in vitreous [ Time Frame: few minutes ]erythropoietin injections had been performed in our department following standard procedures. In selected cases,vitrectomy was performed one to two days after erythropoietin injection to treat diabetic macular edema.During surgery, vitreous samples were obtained via vitreous cutter at the beginning of the procedure.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01131533
|Contact: JiWon Limfirstname.lastname@example.org|
|Korea, Republic of|
|Hallym University Sacred Heart Hoapital||Recruiting|
|Chuncheon, Kangwondo, Korea, Republic of, 200-704|
|Contact: JiWon Lim 82-33-240-5176 email@example.com|